Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infections

Quist, S.R., Fierlbeck, G., Seaton, R.A., Loeffler, J. and Chaves, R.L. (2012) Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infections. International Journal of Antimicrobial Agents, 39(1), pp. 90-91. (doi: 10.1016/j.ijantimicag.2011.08.007)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1016/j.ijantimicag.2011.08.007


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Seaton, Dr Andrew
Authors: Quist, S.R., Fierlbeck, G., Seaton, R.A., Loeffler, J., and Chaves, R.L.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:International Journal of Antimicrobial Agents
ISSN:0924-8579
ISSN (Online):1872-7913
Published Online:05 October 2011

University Staff: Request a correction | Enlighten Editors: Update this record